It's no laughing matter. Hyperadrenergic POTS attacks can send patients rushing to the emergency room. First Geoff tells his hyperPOTS story, then we dig deep into what it is, the new diagnostic criteria, a drug that can help, and a new form of that was recently discovered.
A long COVID study uncovers a subset of patients with microclots and signs of blood vessel damage who, if the findings are validated, might benefit from rarely used treatments.
What happens when you throw ten or so very different ME/CFS studies together? You get some core themes popping out. Check out the blog and see what they are.
Geoff’s Narration The GIST The idea that something in the blood is causing or contributing to ME/CFS, fibromyalgia, and/or long COVID is so tantalizing. For one thing, while it may not be easy to identify that substance, once it is found, the idea that...
Geoff’s Translation The GIST\ Something in the Blood… This was another “passive transfer” study where researchers transferred something in the blood – in this case, IgG antibodies- into laboratory cultures and watched what happened. It...
Please support Health Rising in our Quickie Summer Donation Drive! Our goal is $15,000.Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.